Home | Business News | Browse by Publication | M | M2 Presswire

Vical receives $2.5 million payment from AnGes.

Publication: M2 Presswire
Publication Date: 08-SEP-09
Format: Online
Delivery: Immediate Online Access

Article Excerpt
M2 PRESSWIRE-8 September 2009-Crown Equity Holdings, Inc.: Vical receives $2.5 million payment from AnGes(C)1994-2009 M2 COMMUNICATIONS

RDATE:08092009

CRWENews.com is pleased to announce a stock highlight on Biotechnology company Vical Inc. (VICL) said Tuesday September 8, 2009 it received a $2.5 million payment from AnGes MG Inc. for work on the cancer drug candidate Allovectin-7.

The drug, aimed at treating metastatic melanoma, is now in late-stage development.

The $2.5 million payment is the final installment of $22.6 million...



More articles from M2 Presswire
An Essential and Comprehensive 2009 Report on the Russian UPS Market., September 08, 2009
SpongeTech Delivery Systems Announces Reverse Stock Split to Move Clos..., September 08, 2009
This Essential Q3 2009 Argentina Commercial Banking Report is Now Avai..., September 08, 2009
Ping an Group Launches Ping an One - Online Financial Management Servi..., September 08, 2009
sevenload Now Offering Search Results in 3D., September 08, 2009

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.